1. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
Google Scholar | Crossref | Medline2. Iwasaki, Y, Takaguchi, K, Ikeda, H, et al. Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy. Liver Int 2004; 24: 603–610.
Google Scholar | Crossref | Medline3. Okanoue, T, Itoh, Y, Minami, M, et al. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group. J Hepatol 1999; 30: 653–659.
Google Scholar | Crossref | Medline4. Asahina, Y, Tsuchiya, K, Tamaki, N, et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology 2010; 52: 518–527.
Google Scholar | Crossref | Medline5. Kanwal, F, Kramer, J, Asch, SM, et al. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology 2017; 153: 996–1005.e1001.
Google Scholar | Crossref | Medline6. Zanocco-Marani, T, Bateman, A, Romano, G, et al. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res 1999; 59: 5331–5340.
Google Scholar | Medline | ISI7. Anakwe, OO. Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis. Biol Reprod 1990; 42: 317–328.
Google Scholar | Crossref | Medline8. Zhou, J, Gao, G, Crabb, JW, et al. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem 1993; 268: 10863–10869.
Google Scholar | Crossref | Medline9. Arechavaleta-Velasco, F, Perez-Juarez, CE, Gerton, GL, et al. Progranulin and its biological effects in cancer. Med Oncol 2017; 34: 194.
Google Scholar | Crossref | Medline10. Shoyab, M, McDonald, VL, Byles, C, et al. Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proc Natl Acad Sci U S A 1990; 87: 7912–7916.
Google Scholar | Crossref | Medline | ISI11. Yang, D, Wang, LL, Dong, TT, et al. Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways. Am J Cancer Res 2015; 5: 3085–3097.
Google Scholar | Medline12. He, Z, Bateman, A. Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 1999; 59: 3222–3229.
Google Scholar | Medline | ISI13. Tangkeangsirisin, W, Serrero, G. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 2004; 25: 1587–1592.
Google Scholar | Crossref | Medline | ISI14. Ho, JC, Ip, YC, Cheung, ST, et al. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology 2008; 47: 1524–1532.
Google Scholar | Crossref | Medline | ISI15. He, Z, Ong, CH, Halper, J, et al. Progranulin is a mediator of the wound response. Nat Med 2003; 9: 225–229.
Google Scholar | Crossref | Medline | ISI16. He, Z, Bateman, A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 2003; 81: 600–612.
Google Scholar | Crossref | Medline | ISI17. Lu, Y, Zheng, L, Zhang, W, et al. Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro. Gynecol Oncol 2014; 134: 364–371.
Google Scholar | Crossref | Medline18. Bose, D, Zimmerman, LJ, Pierobon, M, et al. Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Br J Cancer 2011; 105: 1759–1767.
Google Scholar | Crossref | Medline19. Tangkeangsirisin, W, Hayashi, J, Serrero, G. PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Res 2004; 64: 1737–1743.
Google Scholar | Crossref | Medline | ISI20. Kim, WE. PC cell-derived growth factor stimulates proliferation and confers trastuzumab resistance to Her-2-overexpressing breast cancer cells. Clin Cancer Res 2006; 12: 4192–4199.
Google Scholar21. Wang, W, Hayashi, J, Serrero, G. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Clin Cancer Res 2006; 12: 49–56.
Google Scholar | Crossref | Medline22. Cheung, PF, Yip, CW, Wong, NC, et al. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cancer Immunol Res 2014; 2: 1209–1219.
Google Scholar | Crossref | Medline23. Edelman, MJ, Feliciano, J, Yue, B, et al. GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma. Hum Pathol 2014; 45: 1893–1899.
Google Scholar | Crossref | Medline24. Serrero, G, Hawkins, DM, Bejarano, PA, et al. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Diagn Pathol 2016; 11: 08–10.
Google Scholar | Crossref | Medline25. Yamamoto, Y, Goto, N, Takemura, M, et al. Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas. Clin Chim Acta 2017; 473: 139–146.
Google Scholar | Crossref | Medline26. Yamamoto, Y, Takemura, M, Serrero, G, et al. Increased serum GP88 (progranulin) concentrations in rheumatoid arthritis. Inflammation 2014; 37: 1806–1813.
Google Scholar | Crossref | Medline27. Kimura, A, Takemura, M, Saito, K, et al. Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder. J Neuroimmunol 2017; 305: 175–181.
Google Scholar | Crossref | Medline28. Kimura, A, Takemura, M, Serrero, G, et al. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis. J Neurooncol 2018; 137: 455–462.
Google Scholar | Crossref | Medline29. Cheung, PF, Cheng, CK, Wong, NC, et al. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells. PLoS One 2011; 6: e28246.
Google Scholar | Crossref | Medline30. Cheung, ST, Wong, SY, Leung, KL, et al. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 2004; 10: 7629–7636.
Google Scholar | Crossref | Medline | ISI31. Serrero, G, Ioffe, OB. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Hum Pathol 2003; 34: 1148–1154.
Google Scholar | Crossref | Medline | ISI32. Serrero, G, Hawkins, DM, Yue, B, et al. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Res 2012; 14: 02–10.
Google Scholar | Crossref33. Cuevas-Antonio, R, Cancino, C, Arechavaleta-Velasco, F, et al. Expression of progranulin (acrogranin/PCDGF/granulin-epithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line. Cancer Invest 2010; 28: 452–458.
Google Scholar | Crossref | Medline34. Wang, M, Li, G, Yin, J, et al. Progranulin overexpression predicts overall survival in patients with glioblastoma. Med Oncol 2012; 29: 2423–2431.
Google Scholar | Crossref | Medline35. Pan, CX, Kinch, MS, Kiener, PA, et al. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res 2004; 10: 1333–1337.
Google Scholar | Crossref | Medline36. Kim, J-H, Do, I-G, Kim, K, et al. Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma. Cancer Chemother Pharmacol 2016; 78: 1085–1092.
Google Scholar37. Tkaczuk, KR, Yue, B, Zhan, M, et al. Increased circulating level of the survival factor GP88 (progranulin) in the serum of breast cancer patients when compared to healthy subjects. Breast Cancer 2011; 5: 155–162.
Google Scholar | Medline38. Han, JJ, Yu, M, Houston, N, et al. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol Oncol 2011; 120: 5–10.
Google Scholar | Crossref | Medline39. Carlson, AM, Maurer, MJ, Goergen, KM, et al. Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer. Cancer Epidemiol Biomark Prev 2013; 22: 1730–1735.
Google Scholar | Crossref | Medline40. Kostadinova, L, Shive, CL, Zebrowski, E, et al. Soluble markers of immune activation differentially normalize and selectively associate with improvement in AST, ALT, albumin, and transient elastography during IFN-free HCV therapy. Pathog Immun 2018; 3: 149–163.
Google Scholar | Crossref | Medline41. El-Ghammaz, AMS, Azzazi, MO, Mostafa, N, et al. Prognostic significance of serum progranulin level in de novo adult acute lymphoblastic leukemia patients. Clin Exp Med 2020; 20: 269–276.
Google Scholar | Crossref | Medline42. Morgan, RL, Baack, B, Smith, BD, et al. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med 2013; 158: 329–337.
Google Scholar | Crossref | Medline | ISI43. Hiramatsu, N, Oze, T, Takehara, T. Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy. Hepatol Res 2015; 45: 152–161.
Google Scholar | Crossref | Medline44. Vescovo, T, Refolo, G, Vitagliano, G, et al. Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma. Clin Microbiol Infect 2016; 22: 853–861.
Google Scholar | Crossref | Medline45. Asahina, Y, Tsuchiya, K, Nishimura, T, et al. alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology 2013; 58: 1253–1262.
Google Scholar | Crossref | Medline46. Akuta, N, Suzuki, F, Sezaki, H, et al. Complex association of virus- and host-related factors with hepatocellular carcinoma rate following hepatitis C virus clearance. J Clin Microbiol 2019; 57(1): e01463–18.
Google Scholar47. Cheung, PF, Cheung, TT, Yip, CW, et al. Hepatic cancer stem cell marker granulin-epithelin precursor and beta-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget 2016; 7: 21644–21657.
Google Scholar | Crossref | Medline